US › Healthcare

TherapeuticsMD Inc (TXMD)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$2.040.00%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$724,000
Revenue YoY
+84.2%
Net profit
$95,000
Profit YoY
+114.5%
EPS
$0.00
EPS estimate
$0.00
Net margin
13.1%

Key statistics

Market cap
$23.5M
P/E
203.0
Forward P/E
2.3
P/B
0.87
Book value
$2.33
EPS (TTM)
$0.01
52-week high
$2.95
52-week low
$0.99
50-day MA
$2.05
200-day MA
$1.96
Beta
0.59

Analyst view

Analysts rate TherapeuticsMD Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $5.00.

Shareholding

Insiders
7.45%
Institutions
30.38%

Largest institutional holders

FundStake
Rubric Capital Management LP10.30%
Clearline Capital LP5.49%
Squadron Capital Management LLC3.63%
Vanguard Capital Management, LLC3.06%
Tejara Capital Ltd2.99%
ADAR1 Capital Management LLC1.81%
Renaissance Technologies Corp1.26%
Morgan Stanley - Brokerage Accounts1.12%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for TherapeuticsMD Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.